Orbimed Advisors - APTOSE BIOSCIENCES INC ownership

APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 60 filers reported holding APTOSE BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of APTOSE BIOSCIENCES INC
ValueSharesWeighting
Q3 2021$5,656,000
-78.8%
2,594,348
-67.7%
0.06%
-77.0%
Q2 2021$26,660,000
-44.4%
8,030,0000.0%0.27%
-39.9%
Q1 2021$47,979,000
+36.4%
8,030,0000.0%0.45%
+45.8%
Q4 2020$35,171,000
+553.1%
8,030,000
+794.7%
0.31%
+352.9%
Q3 2020$5,385,000
-10.2%
897,541
-5.6%
0.07%
-19.0%
Q2 2020$6,000,000
+53.3%
950,841
+44.3%
0.08%
+27.3%
Q1 2020$3,914,000
-40.0%
659,000
-42.7%
0.07%
-29.0%
Q4 2019$6,521,0001,150,0000.09%
Other shareholders
APTOSE BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Corriente Advisors, LLC 3,430,000$20,580,00010.44%
Consonance Capital Management LP 7,994,904$47,969,0005.84%
P.A.W. CAPITAL CORP 700,000$4,200,0004.57%
Prosight Management, LP 1,139,094$6,835,0003.25%
Voss Capital, LLC 682,579$4,096,0002.34%
Opaleye Management Inc. 1,799,000$10,794,0002.11%
DRW Securities, LLC 4,201,176$25,207,0001.39%
Nantahala Capital Management 6,889,157$41,335,0001.26%
Atlas Principals, LLC 395,000$2,370,0001.19%
SANDERS MORRIS HARRIS LLC 667,004$4,062,0001.10%
View complete list of APTOSE BIOSCIENCES INC shareholders